Holding the line against diagnostic inflation in psychiatry

Psychotherapy and Psychosomatics

Volumn 81, Issue 1, 2011, Pages 5-10

  Batstra, Laura ^a   Frances, Allen ^b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; PLACEBO; PSYCHOTROPIC AGENT;

COGNITIVE THERAPY; DEPRESSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC PROCEDURE; DRUG EFFICACY; DRUG MARKETING; FALSE POSITIVE RESULT; HOSPITAL PATIENT; HUMAN; MENTAL DISEASE; MENTAL HEALTH SERVICE; OUTPATIENT; PATIENT COUNSELING; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROBLEM SOLVING; PROSPECTIVE STUDY; PSYCHIATRIC DIAGNOSIS; PSYCHIATRIC TREATMENT; PSYCHIATRIST; PSYCHOPHARMACOTHERAPY; REVIEW; STEPPED DIAGNOSIS; WATCHFUL WAITING;

ADULT; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FALSE POSITIVE REACTIONS; HUMANS; MENTAL DISORDERS; PSYCHIATRY;

EID: 81555235422     PISSN: 00333190     EISSN: 14230348     Source Type: Journal    
DOI: 10.1159/000331565     Document Type: Review

References (37)

1. Frances A: Problems in defining clinical significance in epidemiological studies. Arch Gen Psychiatry 1998; 55: 119.
2. Kessler RC, Demler O, Frank RG, Olfson M, Pincus HA, Walters EE, Wang P, Wells KB, Zaslavsky AM: Prevalence and treatment of mental disorders, 1990 to 2003. N Engl J Med 2005; 352: 2515-2523. (Pubitemid 41007867)
3. Wang PS, Aguilar-Gaxiola S, Alonso J, Angermeyer MC, Borges G, Bromet EJ, Bruffaerts R, de Girolamo G, de Graaf R, Gureje O, Haro JM, Karam EG, Kessler RC, Kovess V, Lane MC, Lee S, Levinson D, Ono Y, Petukhova M, Posada-Villa J, Seedat S, Wells JE: Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys. Lancet 2007; 370: 841-850. (Pubitemid 47362343)
4. Kravitz RL, Epstein RM, Feldman MD, Franz CE, Azari R, Wilkes MS, Hinton L, Franks P: Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial. JAMA 2005; 293: 1995-2002. (Pubitemid 40570893)
5. National Institute for Health and Clinical Excellence: Depression: the treatment and management of depression in adults-clinical guideline 90. 2009. http://guidance.nice. org.uk/CG90/NICEGuidance/pdf/English (accessed April 6, 2011).
6. Spijker J, van Vliet IM, Meeuwissen JA, van Balkom AJ: Update of the multidisciplinary guidelines for anxiety and depression (article in Dutch). Tijdschr Psychiatr 2010; 52: 715-718.
7. Jenkins R, Meltzer H, Bebbington P, Brugha T, Farrell M, McManus S, Singleton N: The British Mental Health Survey Programme: achievements and latest findings. Soc Psychiatry Psychiatr Epidemiol 2009; 44: 899-904.
8. Feighner JP, Robins E, Guze SB, Woodruff RA Jr, Winokur G, Munoz R: Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 1972; 26: 57-63.
9. Spitzer RL, Endicott J, Robins E: Research diagnostic criteria. Psychopharmacol Bull 1975; 11: 22-25.
10. Robins LN, Helzer JE, Weismann MM, Orvaschel H, Gruenberg E, Burke JD Jr, Regier DA: Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry 1984; 41: 949-958. (Pubitemid 14007854)
11. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE: Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R). Arch Gen Psychiatry 2005; 62: 593-602. (Pubitemid 40973434)
12. de Graaf R, Ten Have M, van Gool C, van Dorsselaer S: Prevalence of mental disorders and trends from 1996 to 2009: results from the Netherlands Mental Health Survey and Incidence Study-2. Soc Psychiatry Psychiatr Epidemiol 2011, E-pub ahead of print.
13. Oakley Browne MA, Wells JE, Scott KM: Te Rau Hinengaro: The New Zealand Mental Health Survey. Wellington, Ministry of Health, 2006.
14. Brugha TS, Bebbington PE, Singleton N, et al: Trends in service use and treatment for mental disorders in adults throughout Great Britain. Br J Psychiatry 2004; 185: 378-384. (Pubitemid 39482073)
15. Slade T, Johnston A, Oakley Browne MA, Andrews G, Whiteford H: National Survey of Mental Health and Wellbeing: methods and findings. Aust NZ J Psychiatry 2009; 43: 594-605.
16. Frances A: A warning sign on the road to DSM-V: beware of its unintended consequences. 2009. http://www.psychiatrictimes. com/print/article/10168/ 1425378?printable =true.
17. Frances A: The First draft of DSM-V. BMJ 2010; 340:c1168.
18. Moffitt TE, Caspi A, Taylor A, Kokaua B, Milne BJ, Polanczyk G, Poulton R: How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. Psychol Med 2010; 40: 899-909.
19. Kessler RC, Chiu WT, Demler O, Walters EE: Prevalence, severity, and comorbidity of twelve-month DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R). Arch Gen Psychiatry 2005; 62: 617-627. (Pubitemid 40973437)
20. US Census Bureau: Population estimates by demographic characteristics. Table 2: annual estimates of the population by selected age groups and sex for the United States-April 1, 2000 to July 1, 2004 (NC-EST2004-02). 2005. http://www.census.gov/popest/national/asrh/.
21. Frances A: Whither DSM-V? Br J Psychiatry 2009; 195: 391-392.
22. Burger H, Neeleman N: A glossary on psychiatric epidemiology. J Epidemiol Community Health 2007; 61: 185-189. (Pubitemid 46579549)
23. Rounsaville B, Alarcon RD, Andrews G, Jackson JS, Kendell RE, Kendler K: Basic nomenclature issues for DSM-V; in Kupfer D, First M, Regier D (eds): A Research Agenda for DSM-V. Washington, American Psychiatric Publishing, 2002, pp 1-30.
24. World Mental Health Survey Consortium: Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA 2004; 291: 2581-2590.
25. IMS: IMS health reports. 2011. http://www. imshealth.com/portal/site/ imshealth/menuitem. a46c6d4df3db4b3d88f611019418c22 a/?vgnextoid= d690a27e9d5b7210VgnVCM1 00000ed152ca2RCRD.
26. Fava GA: The decline of pharmaceutical psychiatry and the increasing role of psychological medicine. Psychother Psychosom 2009; 78: 220-227.
27. Baumeister H: Inappropriate prescriptions of antidepressant drugs in patients with subthreshold to mild depression: time for the evidence to become practice. J Affect Disord DOI: 10.1016/j.jad.2011.05.025.
28. Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC, Fawcett J: Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA 2010; 303: 47-53.
29. Mendel R, Hamann J, Traut-Mattausch E, Bühner M, Kissling W, Frey D: 'What would you do if you were me, doctor?': Randomised trial of psychiatrists' personal v. professional perspectives on treatment recommendations. Br J Psychiatry 2010; 197: 441-447.
30. Kessler RC, Merikangas KR, Berglind P, Eaton WW, Koretz DS, Walters EE: Mild disorders should not be eliminated from the DSM-5. Arch Gen Psychiatry 2003; 60: 1117-1122. (Pubitemid 37429651)
31. Bower P, Gilbody S: Stepped care in psychological therapies: access, effectiveness and efficiency-narrative literature review. Br J Psychiatry 2005; 186: 11-17. (Pubitemid 40070538)
32. Marks I: Mental health clinics in the 21st century. Psychother Psychosom 2009; 78: 133-138.
33. Geldard K, Geldard G: Personal Counseling Skills: An Integrative Approach. Illinois, Charles C Thomas, 2008.
34. Meredith LS, Cheng WJY, Hicky SC, Dwight-Johnson M: Factors associated with primary care clinician's choice of a watchful waiting approach to managing depression. Psychiatr Serv 2007; 58: 72-78.
35. Cape J, Whittington C, Buszewicz M, Wallace P, Underwood L: Brief psychological therapies for anxiety and depression in primary care: meta-analyses and meta-regression. BMC Med 2010; 8: 38.
36. Gingerich WJ, Eisengart S: Solution-focused brief therapy: a review of the outcome research. Fam Process 2000; 39: 477-498.
37. Fava GA, Tomba E: New modalities of assessment and treatment planning in depression. CNS Drugs 2010; 24: 1-13.